v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Total revenues $ 1,443,000 $ 1,455,000 $ 2,543,000 $ 2,655,000
Operating expenses (income):        
Cost of revenues 812,000 824,000 1,512,000 1,506,000
Research and development 0 9,000 0 9,000
Gain on sale of intangible assets 0 0 0 (750,000)
Change in fair value of contingent consideration 0 (1,000,000) 0 (2,000,000)
Selling, general and administrative 1,127,000 2,123,000 2,306,000 3,861,000
Total operating expenses 1,939,000 1,956,000 3,818,000 2,626,000
(Loss) Income from continuing operations (496,000) (501,000) (1,275,000) 29,000
Interest income 2,000 9,000 7,000 216,000
Credit loss 0 (4,489,000) 0 (4,489,000)
Other (loss) income, net (2,781,000) 1,071,000 (4,285,000) 1,071,000
Loss on January 2026 Inducement Offer 0 0 (2,877,000) 0
Valuation loss on June 2026 PIPE (5,423,000) 0 (5,423,000) 0
Change in fair value of common stock warrant and option liabilities 3,083,000 (548,000) 4,274,000 1,314,000
Issuance and offering costs (651,000) 0 (1,072,000) 0
Net (loss) income from continuing operations $ (6,266,000) $ (4,458,000) $ (10,651,000) $ (1,859,000)
Net loss per share attributable to common stockholders:        
Basic $ (2.09) $ (3.26) $ (4.19) $ (1.36)
Diluted $ (2.09) $ (3.26) $ (4.19) $ (1.36)
Weighted-average number of shares used in per share calculations:        
Weighted average shares - Basic 2,992,555 1,367,040 2,540,234 1,366,553
Weighted average shares - Diluted 2,992,555 1,367,040 2,540,234 1,366,553
Product        
Revenues:        
Total revenues $ 1,443,000 $ 1,455,000 $ 2,543,000 $ 2,655,000